Antiphospholipid antibodies and kidney involvement in patients with systemic sclerosis

Clinical Rheumatology

Volumn 28, Issue 8, 2009, Pages 955-959

  Wielosz, Ewa ^a   Dryglewska, Magdalena ^a   Majdan, Maria ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Antiphospholipid antibodies; Proteinuria; Renal function markers; Scleroderma renal crisis; Systemic sclerosis

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; CREATININE; CYSTATIN C; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOPATHOGENESIS; KIDNEY DISEASE; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

ADULT; AGED; ANTIBODIES, ANTIPHOSPHOLIPID; CREATININE; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROTEINURIA; SCLERODERMA, SYSTEMIC; YOUNG ADULT;

EID: 67849119447     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1188-x     Document Type: Article

References (28)

1. Gupta R, Bammigatti C, Dinda AK, Marwaha V, Gupta S (2007) Prevalence of renal involvement in Indian patients with systemic sclerosis. Indian J Med Sci 61:91-96
2. Guerini S, Cavazzana I, Venturelli C, Rozzi M, Turina S, Sottini L, Tardanico R, Franceschini F, Scolari F (2007) Kidney in systemic sclerosis. G Ital Nefrol 24:295-310
3. Wielosz E, Majdan M, Suszek D, Smarz-Widelska I, Korolczuk A, Korobowicz E (2007) Nephrotic syndrome as clinical manifestation of systemic sclerosis. Rheumatol Int 27:1087-1089
4. Helfrich DJ, Banner B, Steen VD, Medsger TA (1989) Normotensive renal failure in systemic sclerosis. Arthritis Rheum 32:1128-1134
5. Steen VD (1994) Renal involvement in systemic sclerosis. Clin Dermatol 12:253-258
6. Steen VD, Syzd A, Johnson JP, Greenberg A, Medsger TA (2005) Kidney disease other than renal crisis in patients with diffuse scleroderma. J Rheumatol 32:649-655
7. Distler JH, Kalden JR, Gray S, Distler O (2004) Vascular changes in the pathogenesis of systemic sclerosis. Z Rheumatol 63:446-450
8. Abraham D, Distler O (2007) How does endothelial cell injury start? The role of endothelin in systemic sclerosis. Arthritis Res Ther 9:2
9. Assous N, Allanore Y, Batteux F, Meune C, Toulon P, Weill B, Kahan A (2005) Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury. Clin Exp Rheumatol 23:199-204
10. Ihn H, Sato S, Fujimoto K, Kikuchi K, Igarashi A, Soma Y, Tamaki K, Takehara K (1996) Measurement of anticardiolipin antibodies by ELISA using B2-glycoprotein I (B2-GPI) in systemic sclerosis. Clin Exp Immunol 105:475-479
11. Lima J, Fonollosa V, Fernandez-Cortijo J, Ordi J, Cuenca R, Khamashta MA, Vilardell M, Simeon PK, Pico M (1991) Platelet activation, endothelial cell dysfunction in absence of anticardiolipin antibodies in systemic sclerosis. J Rheumatol 18:1833-1836
12. LeRoy EC, Black C, Fleishmajer R (1988) Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 15:202-204
13. Cockroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41
14. National-Kidney-Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 39:S1-S266
15. Ho KT, Reveille JD (2003) The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 5:80-93
16. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I, Galaeazzi M, Meroni PL, Derksen RH, de Groot PG, Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quere I, Hachulla E, Vasconcelos C, Roch B, Fernandez-Nebro A, Boffa MC, Hughes GR, Ingelmo M (2002) Antiphospholipid syndrome. Clinical and immunologic manifestations and pattern of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46:1019-1027
17. Picillo U, Migliaresi S, Marcialis MR, Feruzzi AM, Tirri G (1995) Clinical significance of anticardiolipin antibodies in patients with systemic sclerosis. Autoimmunity 20:1-7
18. Pope JE, Thompson A (2000) The frequency and significance of anticardiolipin antibodies in scleroderma. J Rheumatol 27:1450-1452
19. Wielosz E, Majdan M, Zychowska I, Jeleniewicz R (2008) Coexistence of five autoimmune diseases: Diagnostic and therapeutic difficulties. Rheumatol Int 28:913-923
20. Malia RG, Greaves M, Rowlands LM, Lawrence AC, Hume A, Rowell NR, Moult J, Holt CM, Lindsey N, Hughes P (1988) Anticardiolipin antibodies in systemic sclerosis: Immunological and clinical associations. Clin Exp Immunol 73:456-460
21. Steen VD, Medsger TA (1998) Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis and Rheum 41:1613-1619
22. Sulik A, Kowal-Bielecka O, Domysławska I, Chwiećko J, Sierakowski S (2005) The prevalence and clinical significance of antiphospholipid antibodies in the patients with systemic sclerosis-preliminary report. Rocz Akad Med Bialymst 50:228-231
23. Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM (2004) Antiphospholipid Syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies. Arthritis Rheum 50:2569-2579
24. Tektonidou MG (2008) Renal involvement in the antiphospholipid syndrome (APS)-APS nephropathy. Clin RevAllerg 36:131-140. doi: 10.1007/ s1216-008-8112-z
25. Uthman I, Khamashta M (2006) Antiphospholipid syndrome and the kidneys. Semin Arthritis Rheum 35:360-367
26. Wieczorowska -Tobis K, Niemir ZI, Guzik P, Breborowicz D, Oreopoulos DG (2006) Difference in estimated GFR with two different formulas in elderly individuals. Int Urol Nephrol 38:381-385
27. Sato S, Fujimoto M, Hasegawa M, Takehara K (2003) Antiphospholipid antibody in localized scleroderma. Ann Rheum Dis 62:771-774
28. Ichikawa H, Amano T, Fukuda S, Kataoka H, Kawabata K, Nagake Y, Makino H (1998) A case of scleroderma renal crisis with massive pericardial effusion and positivity on antiphospholipid antibody test. Nippon Jinzo Gakkai Shi 40:295-300